Literature DB >> 11011693

Ex vivo canine lens capsular sac explants.

M G Davidson1, M Wormstone, D Morgan, R Malakof, J Allen, M C McGahan.   

Abstract

BACKGROUND: Lens capsular sac explants from human cadaver eyes were used to investigate posterior capsular opacification (PCO). The purpose of this study was to characterize a similar model using canine tissue and to determine whether transferrin (Tf), transforming growth factor beta-2 (TGF-beta2), and insulin-like growth factor-1 (IGF-1) are secreted by lens epithelial cells (LEC) of these ex vivo sacs.
METHODS: The lens from canine eyes was removed by extracapsular cataract extraction, the lens sac dissected free, pinned to a petri dish, and cultured in either serum-supplemented or serum-free medium. Morphologic characteristics and growth rate to confluence on the posterior capsule were studied by phase-contrast microscopy. Vimentin, alpha smooth muscle actin, and panTGF-beta expression by LEC were determined by immunohistochemistry. Tf, TGF-beta2, and IGF-1 levels were measured by ELISA in the supernatant of sacs cultured in serum-free medium.
RESULTS: The mean time to confluence of LEC onto the posterior capsule was 5.4+/-1.1 days (n=22) and 14.7+/-3.7 days (n=14) for sacs in serum-supplemented and serum-free medium, respectively. Following development of confluence, explants displayed opacification and light scatter from cellular proliferation and capsular contraction. Confluent LEC expressed vimentin, alpha smooth muscle actin, and TGF-beta2, and both Tf and TGF-beta2 were secreted into the culture supernatant.
CONCLUSION: Canine lens sac explants have characteristics virtually identical to those of human origin, and appear to be a useful alternative tissue source for this model when human cadaver eyes are unavailable. Tf and TGFbeta-2, but not IGF-1, are secreted by LEC in explanted lens sacs and may influence the proliferation and metaplasia of LEC during the development of PCO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011693     DOI: 10.1007/s004170000158

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  5 in total

1.  Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity.

Authors:  Jennifer L Davis; Na Young Yi; Jacklyn H Salmon; Anna N Charlton; Carmen M H Colitz; Brian C Gilger
Journal:  J Ocul Pharmacol Ther       Date:  2012-02-28       Impact factor: 2.671

2.  The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model.

Authors:  Heather L Chandler; Terah R Webb; Curtis A Barden; Mirunalni Thangavelu; Samuel K Kulp; Ching-Shih Chen; Carmen M H Colitz
Journal:  Mol Vis       Date:  2010-10-29       Impact factor: 2.367

3.  FGF2 antagonizes aberrant TGFβ regulation of tropomyosin: role for posterior capsule opacity.

Authors:  Eri Kubo; Shinsuke Shibata; Teppei Shibata; Etsuko Kiyokawa; Hiroshi Sasaki; Dhirendra P Singh
Journal:  J Cell Mol Med       Date:  2016-12-15       Impact factor: 5.310

4.  Retrospective Analyses of Potential Risk Factors for Posterior Capsule Opacification after Cataract Surgery.

Authors:  Shuang Wu; Nianting Tong; Lin Pan; Xiaohui Jiang; Yanan Li; MeiLing Guo; Hehuan Li
Journal:  J Ophthalmol       Date:  2018-08-05       Impact factor: 1.909

5.  Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.

Authors:  Heather L Chandler; Curtis A Barden; Ping Lu; Donna F Kusewitt; Carmen M H Colitz
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.